News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,585 Results
Type
Article (43999)
Company Profile (312)
Press Release (683274)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (211866)
Career Advice (2097)
Deals (36396)
Drug Delivery (100)
Drug Development (82296)
Employer Resources (176)
FDA (16734)
Job Trends (15322)
News (356151)
Policy (33415)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (89)
Alliances (52468)
ALS (90)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (135)
Approvals (16736)
Artificial intelligence (284)
Autoimmune disease (22)
Automation (16)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (221)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (282)
Cancer (2291)
Cardiovascular disease (177)
Career advice (1756)
Career pathing (31)
CAR-T (159)
Cell therapy (440)
Cervical cancer (19)
Clinical research (66788)
Collaboration (869)
Company closure (1)
Compensation (540)
Complete response letters (19)
COVID-19 (2675)
CRISPR (45)
C-suite (251)
Cystic fibrosis (104)
Data (2232)
Decentralized trials (2)
Denatured (30)
Depression (44)
Diabetes (272)
Diagnostics (6638)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (102)
Drug shortages (27)
Duchenne muscular dystrophy (94)
Earnings (88278)
Editorial (37)
Employer branding (22)
Employer resources (151)
Events (117162)
Executive appointments (748)
FDA (18024)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (781)
Gene editing (113)
Generative AI (26)
Gene therapy (317)
GLP-1 (729)
Government (4518)
Grass and pollen (5)
Guidances (67)
Healthcare (19537)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (30)
Infectious disease (2820)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (100)
Interviews (323)
IPO (16851)
IRA (41)
Job creations (3819)
Job search strategy (1494)
Kidney cancer (10)
Labor market (38)
Layoffs (481)
Leadership (18)
Legal (8128)
Liver cancer (77)
Lung cancer (324)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (312)
MASH (68)
Medical device (14111)
Medtech (14116)
Mergers & acquisitions (20102)
Metabolic disorders (695)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1945)
NextGen: Class of 2025 (6844)
Non-profit (4618)
Now hiring (39)
Obesity (367)
Opinion (217)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (242)
Patient recruitment (113)
Peanut (49)
People (59534)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20961)
Phase II (29384)
Phase III (21812)
Pipeline (1210)
Policy (141)
Postmarket research (2582)
Preclinical (8996)
Press Release (71)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (384)
Real estate (6235)
Recruiting (65)
Regulatory (22865)
Reports (46)
Research institute (2459)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (71)
Series A (137)
Series B (86)
Service/supplier (15)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3841)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (41)
Vaccines (721)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (141)
Last 7 days (945)
Last 30 days (2692)
Last 365 days (33539)
2025 (11016)
2024 (36219)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (759)
Alabama (54)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (40519)
Australia (6739)
California (6257)
Canada (2033)
China (536)
Colorado (273)
Connecticut (285)
Delaware (155)
Europe (88676)
Florida (920)
Georgia (216)
Idaho (60)
Illinois (560)
India (26)
Indiana (316)
Iowa (11)
Japan (165)
Kansas (107)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (906)
Massachusetts (4716)
Michigan (241)
Minnesota (402)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (64)
New Hampshire (69)
New Jersey (1761)
New Mexico (28)
New York (1776)
North Carolina (1016)
North Dakota (9)
Northern California (2714)
Ohio (209)
Oklahoma (15)
Oregon (37)
Pennsylvania (1395)
Puerto Rico (13)
Rhode Island (34)
South America (1154)
South Carolina (23)
South Dakota (1)
Southern California (2348)
Tennessee (103)
Texas (922)
United States (23720)
Utah (187)
Virginia (150)
Washington D.C. (63)
Washington State (570)
West Virginia (3)
Wisconsin (57)
727,585 Results for "bioaffinity technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
April 17, 2025
·
6 min read
Press Releases
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
April 1, 2025
·
11 min read
Press Releases
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
March 20, 2025
·
5 min read
Press Releases
bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
February 25, 2025
·
4 min read
Press Releases
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
March 27, 2025
·
7 min read
Press Releases
bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
March 6, 2025
·
6 min read
Press Releases
bioAffinity Technologies Set for Continued Expansion in 2025
December 12, 2024
·
5 min read
Press Releases
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
January 22, 2025
·
4 min read
Press Releases
bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
January 13, 2025
·
5 min read
Lone Star Bio
bioAffinity Technologies In The News - January 30, 2024
bioAffinity Technologies, Inc. provides a summary of recent Company news.
January 30, 2024
·
5 min read
1 of 72,759
Next
